The surge in the infection prevention and control demand
market is due to factors such as the rising occurrence of chronic
diseases, escalating rates of surgical procedures necessitating
stringent infection prevention measures, a rise in
hospital-acquired infections, increasing government initiatives to
uphold infection prevention standards, expansion of the healthcare
sector, heightened product introductions, and advancements in
product development, among other factors.
LAS
VEGAS, May 22, 2024 /PRNewswire/ --
DelveInsight's Infection Prevention and Control Market
Insights report provides the current and forecast market
analysis, individual leading infection prevention and control
companies' market shares, challenges, infection prevention and
control market drivers, barriers, trends, and key market infection
prevention and control companies in the market.
Key Takeaways from the Infection Prevention and Control
Market Report
- As per DelveInsight estimates, North
America is anticipated to dominate the global infection
prevention and control market during the forecast
period.
- Notable infection prevention and control companies such as
3M, Fortive, Medivators Inc.,
Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex
Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics,
BD, Owens & Minor, Matachana Group, Xenex Disinfection Services
Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC
TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and several
others, are currently operating in the infection prevention and
control market.
- In March 2023, Getinge
completed the acquisition of Ultra Clean Systems Inc., a leading US
manufacturer of ultrasonic cleaning technologies, used in hospitals
and surgery centers to decontaminate surgical instruments.
- In August 2021, Advanced
Sterilization Products, a Fortive company, launched the STERRAD
VELOCITY, a biological Indicator (BI)/process challenge device
(PCD) in Asia.
- In June 2021, Nanosonics
announced the launch of Nanosonics AuditPro, a new infection
prevention digital product platform.
- In June 2021, STERIS plc
completed the previously announced acquisition of Cantel Medical, a
global provider of infection prevention products and services to
endoscopy, dental, dialysis, and life sciences Customers.
To read more about the latest highlights related to the
infection prevention and control market, get a snapshot of the key
highlights entailed in the Global Infection Prevention and
Control Market Report
Infection Prevention and Control Overview
Infection prevention and control (IPC) is a paramount aspect of
healthcare systems worldwide, crucial for safeguarding both
patients and healthcare workers against the spread of infectious
diseases. IPC strategies encompass a multifaceted approach,
integrating stringent hygiene practices, adherence to
evidence-based protocols, and the implementation of robust
surveillance systems. These measures not only mitigate the
transmission of pathogens within healthcare facilities but also
play a pivotal role in containing outbreaks within communities.
From meticulous hand hygiene to the judicious use of personal
protective equipment (PPE), IPC fosters a culture of vigilance and
accountability, underscoring the commitment to patient safety and
the preservation of public health.
Moreover, the significance of IPC extends beyond healthcare
settings, permeating various sectors such as food handling,
hospitality, and even daily interactions within communities. Public
awareness campaigns, education initiatives, and regulatory
standards further bolster the efficacy of IPC practices, empowering
individuals with the knowledge and tools to mitigate infection
risks in diverse environments. In an era marked by emerging
infectious threats and global interconnectedness, the imperative
for robust IPC measures transcends geographical boundaries,
emphasizing the collective responsibility to uphold stringent
infection control protocols as integral pillars of public health
resilience.
Infection Prevention and Control Market Insights
In 2023, North America
dominated the infection prevention and control market due to
various factors such as the increasing prevalence of chronic
diseases like cancer, kidney disease, and Crohn's disease, along
with a rise in hospital-acquired infections and an aging
population. Additionally, there's a strong awareness regarding the
benefits of infection prevention and control practices. This region
is expected to experience substantial growth in the infection
prevention and control market from 2024 to 2030, supported by
factors like consistent strategic collaborations, the presence of
outsourcing organizations, increased healthcare spending, and
advancements in healthcare standards and infrastructure, among
others.
The United States, in
particular, will see a surge in demand for infection prevention and
control devices and consumables due to the escalating prevalence of
hospital-acquired infections. This trend is further fueled by
strategic collaborations undertaken by major market players to
expand their product offerings and infection control capabilities.
For instance, in March 2023, Getinge
acquired Ultra Clean Systems Inc., a prominent US manufacturer
specializing in ultrasonic cleaning technologies used in hospitals
and surgery centers for decontaminating surgical instruments. This
acquisition strengthens infection control practices, particularly
for complex instruments used in procedures like robotic surgery,
minimizing the risk of infections.
Moreover, in March 2019, Getinge
introduced the 9100E Cart Washer in the US infection prevention and
control market, which is an upgraded version of their successful
9100 series floor-loading cart and utensil washer-disinfectors.
This new washer caters specifically to the needs of hospitals by
providing reliable and efficient cleaning for a wide range of
items, including bulky ones like operating table transport trolleys
and instrument containers, which cannot be adequately disinfected
using traditional methods.
To know more about why North
America is leading the market growth in the infection
prevention and control market, get a snapshot of the Infection
Prevention and Control Market Outlook
Infection Prevention and Control Market Dynamics
The infection prevention and control (IPC) market dynamics are
shaped by a myriad of factors, including advancements in
technology, regulatory changes, emerging infectious diseases, and
increased awareness regarding healthcare-associated infections
(HAIs). Technological innovations such as the development of
advanced disinfection techniques, antimicrobial coatings, and rapid
diagnostic tools play a significant role in driving market
growth. Additionally, stringent regulations and guidelines
set by healthcare authorities worldwide propel the demand for IPC
solutions, driving investment in research and development within
the sector.
Furthermore, the global COVID-19 pandemic has
significantly impacted the IPC market dynamics, leading to a surge
in demand for products and services aimed at preventing the spread
of the virus. This unprecedented health crisis has accelerated the
adoption of innovative solutions such as contactless
technologies, UV-C disinfection systems, and personal protective
equipment (PPE). As healthcare facilities, businesses, and public
institutions prioritize infection prevention measures, the IPC
market experiences a substantial expansion, attracting
investments and fostering collaboration among industry
players.
Moreover, the growing emphasis on patient safety, coupled
with the rising healthcare expenditure worldwide, continues to fuel
the growth of the IPC market. Healthcare facilities are
increasingly investing in comprehensive infection prevention
strategies to mitigate the risk of HAIs and improve patient
outcomes. This includes the implementation of robust
surveillance systems, staff training programs, and the adoption
of evidence-based practices. As a result, the IPC market is poised
for steady growth, driven by the ongoing need to address infectious
disease threats and enhance healthcare infrastructure globally.
Get a sneak peek at the infection prevention and control market
dynamics @ Infection Prevention and Control Market Dynamics
Analysis
Report
Metrics
|
Details
|
Coverage
|
Global
|
Study Period
|
2021–2030
|
Infection Prevention
and Control Market CAGR
|
~6%
|
Key Infection
Prevention and Control Companies
|
3M, Fortive, Medivators
Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex
Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics,
BD, Owens & Minor, Matachana Group, Xenex Disinfection Services
Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC
TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, among
others
|
Infection Prevention and Control Market Assessment
- Infection Prevention and Control Market
Segmentation
-
- Infection Prevention and Control Market Segmentation By
Product: Equipment (Sterilization Equipment {Heat Sterilization
Equipment, Low-Temperature Sterilization Equipment, Radiation
Sterilization, And Others} and Disinfectors {Washers, Flushes,
Endoscope Reprocessors, And Others}) and Consumables (Disinfectants
{Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, And
Others}, Personal Protective Equipment {Surgical Drapes, Surgical
Gowns, Gloves, and Others}, Sterilization Consumables, Infectious
Waste Disposal, and Others)
- Infection Prevention and Control Market Segmentation By End
User: Hospitals & Clinics, Medical Device and
Pharmaceutical Companies, and Others
- Infection Prevention and Control Market Segmentation By
Geography: North America,
Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case
Studies, KOL's Views, Analyst's View
Which MedTech key players in the infection prevention and
control market are set to emerge as the trendsetter explore @
Infection Prevention and Control Companies
Table of Contents
1
|
Report
Introduction
|
2
|
Executive
summary
|
3
|
Regulatory and Patent
Analysis
|
4
|
Key Factors
Analysis
|
5
|
Porter's Five Forces
Analysis
|
6
|
Infection Prevention
and Control Market Layout
|
7
|
Global Company Share
Analysis – Key 3-5 Companies
|
8
|
Infection Prevention
and Control Market Company and
Product Profiles
|
9
|
Project
Approach
|
10
|
About
DelveInsight
|
Interested in knowing the infection prevention and control
market by 2030? Click to get a snapshot of the Infection
Prevention and Control Market Trends
Related Reports
Irritable Bowel Syndrome Market
Irritable Bowel Syndrome Market Insights, Epidemiology, and
Market Forecast – 2032 report deliver an in-depth
understanding of the disease, historical and forecasted
epidemiology, as well as the market trends, market drivers, market
barriers, and key irritable bowel syndrome companies, including
Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals,
OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited,
Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic
Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals,
Novome Biotechnologies, Renexxion, Sentia Medical Sciences,
Serentrix LLC, Vitality Biopharma, among others.
Ulcerative Colitis Market
Ulcerative Colitis Market Insights, Epidemiology, and Market
Forecast – 2032 report delivers an in-depth understanding
of the market trends, market drivers, market barriers, and key
Ulcerative Colitis companies, including Eli Lilly and Company,
Lipid Therapeutics, Hoffmann-La Roche, Arena Pharmaceuticals, InDex
Pharmaceuticals, EA Pharma, Theravance Biopharma, Boehringer
Ingelheim, Janssen Research & Development, Lycera, LG Chem,
Iltoo Pharma, Immunic, Hutchison Medipharma, Tianjin Hemay
Pharmaceutical, Celgene, among others.
Crohn's Disease Pipeline
Crohn's Disease Pipeline Insight –
2024 report provides comprehensive insights about the
pipeline landscape, pipeline drug profiles, including clinical and
non-clinical stage products, and the key Crohn's
disease companies, including Janssen, RedHill Biopharma,
Amgen, Pfizer, Prometheus Biosciences, AgomAb Therapeutics,
Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene,
AstraZeneca, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax,
Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem
Inc., Stero Biotechs, Reistone Biopharma Company Limited, Qu
Biologics, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda
Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare,
4D Pharma, Landos Biopharma, Janssen, Roche, Eisai, Bristol-Myers
Squibb, Iltoo Pharma, Suzhou Connect Biopharmaceuticals, Theravance
Biopharma, TaiwanJ Pharmaceuticals, Celularity, Cerecor,
GlaxoSmithKline, KangStem Biotech, Immunic, Alpha Cancer
Technologies, Koutif Therapeutics, Tract Therapeutics, Trio
medicines, ChemoCentryx, Algernon Pharmaceuticals, Neuclone, JHL
Biotech, Innovative Pharmacological Research (IPHAR) Co Ltd,
Innovation Pharmaceuticals, Exeliom Biosciences SAS, AbbVie, Finch
Therapeutics, Akeso Biopharma, Draconis Pharma, MakScientific,
Engitix, Origo Biopharma, Navidea Biopharmaceuticals, Orchard
Therapeutics, Xbrane, Thetis Pharmaceuticals, Temisis Therapeutics,
Synedgen, Synlogic, Morphic Therapeutic, Metacrine, Curacle,
Commence Bio Inc, Cloud Pharmaceuticals, Chong Kun Dang
Pharmaceutical Corp, Avobis Bio LLC, Avexegen Therapeutics,
Assembly Biosciences, Aibios Co Ltd, Aclaris Therapeutics, Athos
Therapeutics, Denali Therapeutics, Educell doo, among
others.
Irritable Bowel Syndrome Pipeline
Irritable Bowel Syndrome Pipeline Insight –
2024 report provides comprehensive insights about the
pipeline landscape, pipeline drug profiles, including clinical and
non-clinical stage products, and the key irritable bowel
syndrome companies, including Arena Pharmaceuticals, 4D
Pharma, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma
Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm,
Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo
Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical
Sciences, Serentrix LLC, Vitality Biopharma, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports
pharma companies by providing comprehensive end-to-end solutions to
improve their performance.
Contact Us
Shruti
Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo:
https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-infection-prevention-and-control-market-is-likely-to-increase-at-a-steady-growth-rate-of-6-by-2030--delveinsight-302152405.html
SOURCE DelveInsight Business Research, LLP